Literature DB >> 18537658

Probiotics in intestinal and non-intestinal infectious diseases--clinical evidence.

K Hatakka1, M Saxelin.   

Abstract

There is increasing evidence that certain probiotic strains can be useful in improving human health. The use of probiotics has received attention as a natural way of restoring body's normal microbiota, and an alternative and inexpensive way of preventing or treating infectious diseases without side effects. The best-documented clinical application of probiotics comes from trials on the treatment of gastrointestinal infections, mainly infectious diarrhoea. The enhancement of local as well as systemic immune responses by probiotics also offers new opportunities for probiotics in preventing infections at distal mucosal surfaces, such as those in the oral cavity, respiratory and urogenital tracts. The underlying mechanisms of probiotics are still unclear, but may include strengthening of the non-immunological gut barrier, interference with pathogen adhesion and growth inhibition, and the enhancement of the local mucosal immune system in the gut, as well as of the systemic immune response.

Entities:  

Mesh:

Year:  2008        PMID: 18537658     DOI: 10.2174/138161208784480162

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  13 in total

1.  Short-term consumption of probiotic lactobacilli has no effect on acid production of supragingival plaque.

Authors:  Aino Marttinen; Anna Haukioja; Sára Karjalainen; Lotta Nylund; Reetta Satokari; Carina Öhman; Pernilla Holgerson; Svante Twetman; Eva Söderling
Journal:  Clin Oral Investig       Date:  2011-07-06       Impact factor: 3.573

Review 2.  Anti-infective properties of bacteriocins: an update.

Authors:  Riadh Hammami; Benoit Fernandez; Christophe Lacroix; Ismail Fliss
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

3.  Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood.

Authors:  Teemu J Taipale; Kaisu Pienihäkkinen; Erika Isolauri; Jorma T Jokela; Eva M Söderling
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

4.  Stability and Inhibitory Activity of Pediocin PA-1 Against Listeria sp. in Simulated Physiological Conditions of the Human Terminal Ileum.

Authors:  Gwenaëlle Le Blay; Riadh Hammami; Christophe Lacroix; Ismaïl Fliss
Journal:  Probiotics Antimicrob Proteins       Date:  2012-12       Impact factor: 4.609

5.  Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.

Authors:  Eva M Söderling; Aino M Marttinen; Anna L Haukioja
Journal:  Curr Microbiol       Date:  2010-09-11       Impact factor: 2.188

6.  Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages.

Authors:  Minja Miettinen; Taija E Pietilä; Riina A Kekkonen; Matti Kankainen; Sinikka Latvala; Jaana Pirhonen; Pamela Österlund; Riitta Korpela; Ilkka Julkunen
Journal:  Gut Microbes       Date:  2012-08-16

7.  Survival and Metabolic Activity of Pediocin Producer Pediococcus acidilactici UL5: Its Impact on Intestinal Microbiota and Listeria monocytogenes in a Model of the Human Terminal Ileum.

Authors:  Benoît Fernandez; Patricia Savard; Ismail Fliss
Journal:  Microb Ecol       Date:  2015-07-11       Impact factor: 4.552

8.  Probiotics and oral health.

Authors:  Anna Haukioja
Journal:  Eur J Dent       Date:  2010-07

9.  Effects of FR-91 on immune cells from healthy individuals and from patients with non-Hodgkin lymphoma.

Authors:  V R M Lombardi; E Martínez; R Chacón; I Etcheverría; R Cacabelos
Journal:  J Biomed Biotechnol       Date:  2009-07-06

10.  Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations.

Authors:  Samira Soltani; Riadh Hammami; Paul D Cotter; Sylvie Rebuffat; Laila Ben Said; Hélène Gaudreau; François Bédard; Eric Biron; Djamel Drider; Ismail Fliss
Journal:  FEMS Microbiol Rev       Date:  2021-01-08       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.